Tuesday, October 15, 2024
Workshop A: Data Science and Artificial Intelligence
8:30 TBD
Mark A. Clements, MD, PhD, CPI, FAAP
Children’s Mercy Hospital, Kansas City, Missouri, USA
8:45 TBD
Ali Cinar, PhD
Illinois Institute of Technology, Chicago, Illinois, USA
9:00 TBD
Andrea Facchinetti, PhD
Department of Information Engineering, University of Padova, Padova, Italy
9:15 TBD
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
9:30 TBD
Nestoras Mathioudakis, MD
Johns Hopkins University, Baltimore, MD
9:45 Q&A
10:00 BREAK
Workshop A: Real World Evidence for Diabetes Trials
10:30 Student Gold Research Award Winner
10:45 Julia K. Mader, MD
Division of Endocrinology and Diabetology, Department of Internal Medicine, Medical University of Graz, Austria
11:00 Rohit Vashisht, PhD
University of California, San Francisco, San Francisco, California, USA
11:15 Shahid Shah, M.Sc.
Netspective Communications, Landover, Maryland, USA
11:30 Panel Discussion
12:00 LUNCH
Workshop B: New Diagnostic Tests
13:15 Current Research Programs at Breakthrough T1D
Aaron Kowalski, PhD
Breakthrough T1D, New York City, New York, USA
13:30 Antibodies to Diagnose Diabetes
Zoe Quandt, MD
Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, California, USA
13:45 Continuous Insulin Monitoring
Joseph Wang, PhD
University of California, San Diego, San Diego, California, USA
14:00 Cardiac Blood Pressure and Exercise Monitoring
Ambarish Pandey, MD
UT Southwestern Medical Center, Dallas, Texas, USA
14:15 Qualitative Hypoglycemia Detection
Gerard L. Coté, PhD
Department of Biomedical Engineering, Texas A&M University, College Station, Texas, USA
14:30 Q&A
14:40 BREAK
Workshop B: Drugs, Insulin and Technology
15:10 Storage of Insulin
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
15:25 Use of GLP-1 RAs Before Surgery
Sun H. Kim, MD
Department of Medicine – Endocrinology, Gerontology, and Metabolism, Stanford University School of Medicine, Stanford, California, USA
15:40 New Insulins
Zan Fleming, MD
Kinexum, Harpers Ferry, West Virginia, USA
15:55 Cell Therapy for Delivering Insulin
Felicia Pagliucia, PhD
Vertex Pharmaceuticals, Boston, MA, USA
16:10 TBD
TBD
16:25 Q&A
16:30 Poster Session
Wednesday, October 16, 2024
8:00 Welcome and Introduction
David Klonoff, MD, FACP, FRCP (Edin), Fellow AIMBE
Mills-Peninsula Medical Center, San Mateo, California, USA
8:05 Keynote Presentation - How is the FDA OIVD evolving to regulate new technologies?
Marianela Perez-Torres, PhD
Director of Division of Chemistry and Toxicology Devices, U.S. Food and Drug Administration, Silver Spring, Maryland, USA
Session 1: Big Tech
8:30 Panelists
Erich Huang, MD, PhD
Verily, South San Francisco, California, USA
Alyssa Patel, PharmD, BCACP
Clinical Pharmacist, Chronic Care, One Medical, San Francisco, California, USA
Aiman Abdel-Malek, PhD
Thirdwayv Inc. and Apex Medical Ai Inc., La Jolla, CA
Praveen Raja, PhD
Samsung Research America
8:35 Panel Discussion
9:40 BREAK
Session 2: New Uses of CGMs
10:10 Nutrition Monitoring for Diabetes
David Kerr, MBChB, DM, FRCP, FRCPE
Sutter Health, Santa Barbara, California, USA
10:25 Use of CGMs by Elite Athletes
Howard Zisser, MD
University of California Santa Barbara, Santa Barbara, CA, USA
10:40 CGM for Prediabetes
Michael P. Snyder, PhD
Department of Genetics, Stanford University, Palo Alto, California, USA
10:55 Q&A
Session 3: Who Can Sell Your Data
11:05 An Oceania Perspective
Geoff Chase, PhD
University of Canterbury, Christchurch, New Zealand
11:15 A European Perspective
Eva Winkler, MD, PhD
University of Heidelberg, Heidelberg, Germany
11:20 An Industry Perspective
Jamie E. Darch, JD
Ropes & Gray LLP, Chicago, Illinois, USA
11:35 A United States Perspective
Bonnie Odom, JD, MPH
Epstein Becker & Green, P.C., San Diego, California, USA
11:50 Q&A
12:00 LUNCH
Session 4: Payers/Economics for Digital Health Interventions
13:15 Panelists
Amanda Adler, MD, PhD, FRCP
Churchill Hospital, Oxford, United Kingdom
Warris Bokhari, MBBS
NewCo Health, Tempe, Arizona, USA
Jordan Silberman, MD, PhD
Elevance Health, Indianapolis, Indiana, USA
Paul Radensky, MD, JD
McDermot Will & Emery Consulting, Washington, DC, USA
13:20 Panel Discussion
Session 5: Analyzing Data from a CGM
14:15 Tight Time in Range
Peter Calhoun, PhD
Jaeb Center for Health Research, Tampa, Florida, USA
14:27 The Diabetes Data Dock
Boris Kovatchev, PhD
University of Virginia, Charlottesville, Virginia, USA
14:39 Glycemia Risk Index
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA
14:51 Interpreting CGM Data with the GRI
Ralph Oiknine, MD
SweetSpot, Saint Louis, Missouri, USA
15:03 Q&A
15:15 BREAK
Session 6: How to Improve Artificial Pancreas Performance
15:45 Incorporating Exercise into Closed Loop Algorithms
Peter G. Jacobs, PhD
Oregon Health & Science University, Portland, Oregon, USA
15:57 Female Fertility and AID performance: Menses and Pregnancy
Carol Levy, MD, CDCES
Division of Endocrinology, Diabetes, and Metabolism, Icahn School of Medicine at Mount Sinai, New York City, New York, USA
16:09 Bihormonal Closed Loop Control
Steven J. Russell, MD, PhD
Massachusetts General Hospital Diabetes Research Center, Boston, Massachusetts, USA
16:21 The Use of GLP-1RAs with AIDs
Viral N. Shah, MD
Division of Endocrinology and Metabolism, Indiana University School of Medicine, Indianapolis, Indiana, USA
16:33 Q&A
16:45 Poster Session
Thursday, October 17, 2024
Session 7: Can Tech Improve Adherence to Diabetes Rx?
8:00 A Summary of the 2024 NIDDK DHT in T2D Research Gaps Workshop
Henry B. Burch, MD
Program Director, Division of Diabetes, Endocrinology, & Metabolic Diseases,
National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, MD
8:12 TBD
Paula Voorheis, PhD
Lunenfeld-Tanenebaum Research Institute, Sinai Health System, Toronto, ON, CAN
8:24 TBD
Wei-An (Andy) Lee, DO
Los Angeles General Medical Center, Los Angeles, California, USA
8:36 TBD
William Polonsky, PhD
Behavioral Diabetes Institute & University of California, San Diego, San Diego, California, USA
8:48 Q&A
Session 8: Accuracy of Diabetes Devices
9:00 The New DTS Error Grid and Trend Accuracy Matrix
Michael Kohn, MD, MPP
University of California, San Francisco, San Francisco, California, USA
9:15 Reliability and Comparability of CGM Performance Endpoints
Guido Freckmann, MD
Institute for Diabetes Technology at Ulm University, Ulm, Germany
9:30 Limitations of Using the MARD for Accuracy
Jan Krouwer, PhD
Krouwer Consulting, Sherborn, MA
9:45 Q&A
9:55 BREAK
Session 9: Innovation Challenge
10:25 Open Innovation Challenge
Diabetes Center Berne, Berne, Switzerland
11:30 LUNCH
Session 10: Physiology of Inserted and Implanted Devices
12:45 The Science of Extended Wear Infusion Sets
Rayhan Lal, MD
Stanford University, Palo Alto, CA, USA
12:57 Update on Optical Glucose Measurement
Mark A. Arnold, PhD
The University of Iowa, Iowa City, Iowa, USA
13:09 TBD
Irl B. Hirsch, MD
University of Washington, Seattle, Washington, USA
13:21 Implanted Technology for Measuring Glucose
Mark Tapsak, PhD
GlucoTrack, Rutherford, New Jersey, USA
13:33 Q&A
Session 11: Performance of a CGM
13:45 Update from Abbott
Mahmood Kazemi, MD
Abbott Diabetes Care, Chicago, Illinois, USA
13:55 Update from Dexcom
Jessica Castle, MD
Dexcom, Inc, San Diego, California, USA
14:05 Update from Medtronic
Lou Lintereur , MS
Medtronic Diabetes, Los Angeles, CA, USA
14:15 Update from Roche
Timor Glatzer, PhD
Roche Diabetes Care, Inc, Indianapolis, Indiana, USA
14:25 Update from Senseonics
Hari Sree, PhD
Senseonics Inc., Germantown, Maryland, USA
14:35 Q&A
14:45 BREAK
Session 12: Hot Topics
15:15 ChatGPT Applied to Diabetes
Sultan A. Meo, MBBS, Ph.D, MMed Ed, FRCP
College of Medicine, King Saud University, Riyadh, Saudi Arabia
15:30 Green Diabetes Project
Lutz Heinemann, PhD
Science Consulting in Diabetes, Düsseldorf, Germany
15:45 Use of CGMs in People without Diabetes
Tracey McLaughlin, MD, MPH
Stanford School of Medicine
16:00 Continuous Glucose Monitoring (CGM)-Based Titration of Once-Weekly Insulin Icodec in Insulin-Naïve Individuals with Type 2 Diabetes (ONWARDS 9)
Richard Bergenstal, MD
International Diabetes Center, Minneapolis, MN, USA
Session 13: Live Demonstration
16:20 TBD
TBD